| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 1 year | ₹60,000 | ₹65,009 | +8.35% | |
| 3 years | ₹1,80,000 | ₹2,13,990 | +18.88% | |
| 5 years | ₹3,00,000 | ₹4,61,523 | +53.84% | |
| 10 years | ₹6,00,000 | ₹15,77,051 | +162.84% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 7.89% |
| Abbott India Ltd | Healthcare | Equity | 5.66% |
| Divi's Laboratories Ltd | Healthcare | Equity | 5.41% |
| Healthcare Global Enterprises Ltd | Healthcare | Equity | 5.25% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 5.14% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.73% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 4.55% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.28% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 4.02% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 3.22% |
| Syngene International Ltd | Healthcare | Equity | 3.17% |
| Procter & Gamble Health Ltd | Healthcare | Equity | 3.15% |
| Lupin Ltd | Healthcare | Equity | 3.13% |
| Cipla Ltd | Healthcare | Equity | 3.08% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 2.99% |
| Natco Pharma Ltd | Healthcare | Equity | 2.86% |
| FDC Ltd | Healthcare | Equity | 2.69% |
| Bayer CropScience Ltd | Materials | Equity | 2.68% |
| Pfizer Ltd | Healthcare | Equity | 2.40% |
| Ami Organics Ltd | Healthcare | Equity | 2.40% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 2.33% |
| Biocon Ltd | Healthcare | Equity | 2.23% |
| Navin Fluorine International Ltd | Materials | Equity | 2.15% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | Equity | 1.99% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.59% |
| Alkem Laboratories Ltd | Healthcare | Equity | 1.40% |
| Dr. Agarwal’S Health Care Ltd. | Healthcare | Equity | 1.31% |
| Gillette India Ltd | Consumer Staples | Equity | 1.25% |
| Nestle India Ltd | Consumer Staples | Equity | 1.09% |
| Sumitomo Chemical India Ltd | Materials | Equity | 1.01% |
| Prasol Chemicals Ltd. | Materials | Equity | 0.85% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 0.69% |
| Zim Laboratories Ltd | Healthcare | Equity | 0.57% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 0.57% |
| Molbio Diagnostics Ltd. | Healthcare | Equity | 0.53% |
| Gujarat Fluorochemicals Ltd | Materials | Equity | 0.51% |
| Symbiotec Pharmalab Ltd. | Healthcare | Equity | 0.48% |
| PI Industries Ltd | Materials | Equity | 0.46% |
| Repo | Unspecified | Repo | 0.19% |
| Cash/Net Current Assets | Unspecified | Cash/Net Current Assets | 0.07% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 0.03% |
| Ipca Laboratories Ltd | Healthcare | Equity | 0.00% |
| Name | 3Y | 5Y | 10Y | All |
|---|---|---|---|---|
| Fund returns | +18.4% | +15.8% | +15.8% | +13.5% |
| Category average (Equity Sectoral) | +23.0% | +17.3% | +16.2% | +17.6% |
| Rank (Equity Sectoral) | 11 | 6 | 4 | -- |